Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 2/20 | 0.54 |
| ▸ | ADH1C | P00326 | 2/20 | 0.54 |
| ▸ | ADH1A | P07327 | 2/20 | 0.54 |
| ▸ | ADH4 | P08319 | 2/20 | 0.54 |
| ▸ | ADH7 | P40394 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3852048 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL111148 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL18251822 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL16350215 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL5134696 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL1869609 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL22700 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL21869 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL3844523 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL1129967 | 1.00 | ADH1B (0.54) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705270-A1 | HYDROFORMYLATION PROCESS | Dow Technology Investments LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4634148-A1 | PROCESS TO MINIMIZE POLYPHOSPHINE USAGE BY MAKING USE OF DEGRADATION PRODUCTS | Dow Technology Investments LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4608553-A1 | HETEROGENEOUS CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4448171-B1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4448170-B1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-08-20 | — | — | EP | disclosed |
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2025029349-A1 | HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-12-05 | — | — | US | disclosed |
| WO-2024228768-A1 | HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-11-07 | — | — | WO | disclosed |
| EP-3990176-B1 | PROCESS TO PREPARE SOLUTION FROM HYDROFORMYLATION PROCESS FOR PRECIOUS METAL RECOVERY | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-11-06 | — | — | EP | disclosed |
| US-5183943-A | REACTIVATION OF HYDROFORMYLATION CATALYSTS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-02-02 | — | — | US | disclosed |
| US-5180854-A | Separation of aldehyde from rhodium phosphorous ligand with solvent | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-01-19 | — | — | US | disclosed |
| EP-0357997-B1 | REACTIVATION OF HYDROFORMYLATION CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1992-11-25 | — | — | EP | disclosed |
| EP-0504814-A2 | Reactivation of hydroformylation catalysts | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1992-09-23 | — | — | EP | disclosed |
| EP-0389617-A1 | TREATMENT OF RHODIUM CATALYSTS. | UNION CARBIDE CHEM PLASTIC (US) | 1990-10-03 | — | — | EP | disclosed |
| US-4929767-A | PRETREATING AN ORGANIC SOLUTION OF A DEACTIVATED RHODIUM-PHOSPHINE COMPLEX TO IMPROVE RHODIUM EXTRACTABILITY INTO AN AQUEOUS SOLUTION; REUSE | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) | 1990-05-29 | — | — | US | disclosed |
| WO-1990003841-A1 | TREATMENT OF RHODIUM CATALYSTS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) | 1990-04-19 | — | — | WO | disclosed |
| EP-0357997-A1 | Reactivation of hydroformylation catalysts | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1990-03-14 | — | — | EP | disclosed |
| EP-0350922-A2 | Process for catalyst-aldehyde product separation | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) | 1990-01-17 | — | — | EP | disclosed |
| US-4861918-A | RHODIUM-TERITARY ORGANOPHOSPHINE COMPLEX | UNION CARBIDE CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250128245-A1 | COMPOUNDS, TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | C1R, M6PR, FOLR1 | ADH1B 2359/4885ADH1C 2249/4885ADH1A 2862/4885 |
| US-20240399349-A1 | TRANSITION METAL COMPLEX HYDROFORMYLATION CATALYST PRECUROR COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND HYDROFORMYLATION PROCESSES | M6PR, KRAS, C1R | ADH1B 1496/4885ADH1C 1486/4885ADH1A 1761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.